Bespoke Extracts Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Bespoke Extracts's earnings have been declining at an average annual rate of -8.1%, while the Pharmaceuticals industry saw earnings declining at 0.2% annually. Revenues have been growing at an average rate of 84.1% per year.
Belangrijke informatie
-8.1%
Groei van de winst
10.0%
Groei van de winst per aandeel
Pharmaceuticals Groei van de industrie | 6.0% |
Inkomstengroei | 84.1% |
Rendement op eigen vermogen | n/a |
Nettomarge | -110.1% |
Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Opbrengsten en kosten
Hoe Bespoke Extracts geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Jun 24 | 1 | -1 | 2 | 0 |
31 Mar 24 | 1 | -1 | 2 | 0 |
31 Dec 23 | 1 | -1 | 2 | 0 |
30 Sep 23 | 1 | -2 | 2 | 0 |
30 Jun 23 | 0 | -3 | 3 | 0 |
31 Mar 23 | 0 | -4 | 4 | 0 |
31 Dec 22 | 0 | -4 | 4 | 0 |
30 Sep 22 | 0 | -3 | 3 | 0 |
30 Jun 22 | 0 | -2 | 2 | 0 |
31 Mar 22 | 0 | -1 | 2 | 0 |
31 Dec 21 | 0 | 0 | 1 | 0 |
30 Nov 21 | 0 | -1 | 1 | 0 |
31 Aug 21 | 0 | -1 | 1 | 0 |
31 May 21 | 0 | -1 | 1 | 0 |
28 Feb 21 | 0 | -4 | 4 | 0 |
31 Dec 20 | 0 | -1 | 1 | 0 |
30 Nov 20 | 0 | -4 | 4 | 0 |
31 Aug 20 | 0 | -5 | 4 | 0 |
31 May 20 | 0 | -5 | 4 | 0 |
29 Feb 20 | 0 | -2 | 1 | 0 |
30 Nov 19 | 0 | -2 | 1 | 0 |
31 Aug 19 | 0 | 3 | -3 | 0 |
31 May 19 | 0 | 1 | -1 | 0 |
28 Feb 19 | 0 | -1 | 1 | 0 |
30 Nov 18 | 0 | -3 | 2 | 0 |
31 Aug 18 | 0 | -8 | 7 | 0 |
31 May 18 | 0 | -7 | 6 | 0 |
28 Feb 18 | 0 | -9 | 9 | 0 |
30 Nov 17 | 0 | -8 | 8 | 0 |
31 Aug 17 | 0 | -7 | 7 | 0 |
31 May 17 | 0 | -5 | 5 | 0 |
28 Feb 17 | 0 | 0 | 0 | 0 |
30 Nov 16 | 0 | 0 | 0 | 0 |
31 Aug 16 | 0 | 0 | 0 | 0 |
31 May 16 | 0 | -1 | 0 | 0 |
29 Feb 16 | 0 | -1 | 0 | 0 |
30 Nov 15 | 0 | -1 | 0 | 0 |
31 Aug 15 | 0 | -1 | 0 | 0 |
31 May 15 | 0 | 0 | 0 | 0 |
28 Feb 15 | 0 | 0 | 0 | 0 |
30 Nov 14 | 0 | 0 | 0 | 0 |
31 Aug 14 | 0 | 0 | 0 | 0 |
31 May 14 | 0 | 0 | 0 | 0 |
28 Feb 14 | 0 | 0 | 0 | 0 |
Kwaliteitswinsten: BSPK is currently unprofitable.
Groeiende winstmarge: BSPK is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: BSPK is unprofitable, and losses have increased over the past 5 years at a rate of 8.1% per year.
Versnelling van de groei: Unable to compare BSPK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: BSPK is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (12.4%).
Rendement op eigen vermogen
Hoge ROE: BSPK's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.